Aria Diagnostics Revenue and Competitors

Our mission is to produce high quality drug testing results using professionally developed and validated methodologies designed to detect prescription narcotics, opiates/opioids, sedatives, gabapentanoids, antipsychotics/antidepressants, stimulants, and drugs of abuse. Specimens are subjected to presumptive drug screen and validity testing through automated Enzyme-Linked Immunoassay. Manually approved results determine if the specimens qualify for confirmation. Using LC-MS/MS (liquid chromatography-tandem mass spectrometry), separation of more than 100 drugs and mass spectrometry analysis can be achieved in as little as six minutes per specimen. Headquartered in Indianapolis, Indiana, our laboratory is a high-complexity, CLIA-certified, CAP-accredited facility. Our skilled team of lab personnel possesses over 70 years of clinical laboratory experience and review data a minimum of three times before reporting results to clients. Never compromising quality for an increased rate of production, all procedures are implemented following CAP standards of patient care and safety. Our lab yields results that enable clinicians to make informed decisions regarding care that will ultimately reduce abuse, misuse, and diversion of harmful drugs.